Crossroads Health Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Allinaire Therapeutics Inc.Apr 2026SEC filingmedium confidence
BiotechCleveland, US
Douglas W.P. Hay(Executive Officer, Director)Ted Torphy(Manager)Baiju Shah(Manager and Chairman)Brian Stemme(Manager)
BoardSatish Jindal(Director)
Board seatSamantha Ginther· per SEC Form D · $700K raise · filed Apr 2026
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.